A Randomized Controlled Comparison of Azithromycin and Ofloxacin for Treatment of Multidrug-Resistant or Nalidixic Acid-Resistant Enteric Fever
Nguyen Tran Chinh, Christopher M. Parry, Nguyễn Thị Lý, Huynh Duy Ha et autres
To examine the efficacy and safety of short courses of azithromycin and ofloxacin for treating multidrug-resistant (MDR, i.e., resistant to chloramphenicol, ampicillin, and cotrimoxazole) and nalidixic acid-resistant enteric fever, azithromycin (1 g once daily for 5 days at 20 mg/kg/day) and ofloxacin …
vn, gb (code pays fourni par la source)
149 citations
Antimicrobial Agents and Chemotherapy